ChEMBL ID: CHEMBL4650256
Mechanism of action: Receptor protein-tyrosine kinase erbB-2 inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to ZANIDATAMAB